共 35 条
- [21] Wang M., Et al., Sonoporation-induced cell membrane permeabilization and cytoskeleton disassembly at varied acoustic and microbubble-cell parameters, Sci. Rep, 8, 1, (2018)
- [22] Yang Y., Li Q., Guo X., Tu J., Zhang D., Mechanisms underlying sonoporation: Interaction between microbubbles and cells, Ultrason. Sonochem, 67, (2020)
- [23] Qu N., Et al., Breast Cancer cell line phenotype affects Sonoporation Efficiency under Optimal Ultrasound Microbubble conditions, Med. Sci. Monitor: Int. Med. J. Experimental Clin. Res, 24, pp. 9054-9062, (2018)
- [24] Qiu F., Chen J., Cao J., Diao F., Huang P., Lowintensity lowfrequency ultrasound enhances the chemosensitivity of gemcitabineresistant ASPC-1 cells via PI3K/AKT/NFκB pathwaymediated ABC transporters, Oncol. Rep, 44, 3, pp. 1158-1168, (2020)
- [25] Zhu M.M., Et al., Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer, PloS One, 7, 8, (2012)
- [26] Liu X.Y., Liu S.P., Jiang J., Zhang X., Zhang T., Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein, Eur. Rev. Med. Pharmacol. Sci, 20, 6, pp. 1098-1108, (2016)
- [27] Alatrash G., Jakher H., Stafford P.D., Mittendorf E.A., Cancer immunotherapies, their safety and toxicity, Exp. Opin. Drug Saf, 12, 5, pp. 631-645, (2013)
- [28] Wu Q., Et al., Selective inhibitors for JNK signalling: a potential targeted therapy in cancer, J. Enzyme Inhib. Med. Chem, 35, 1, pp. 574-583, (2020)
- [29] Wang P.P., Et al., Astragaloside IV downregulates the expression of MDR1 in Bel-7402/FU human hepatic cancer cells by inhibiting the JNK/cJun/AP-1 signaling pathway, Mol. Med. Rep, 16, 3, pp. 2761-2766, (2017)
- [30] Huang Y.C., Pan W., Li H., Yan T., c-Jun NH2-terminal kinase suppression significantly inhibits the growth of transplanted breast tumors in mice, J. Int. Med. Res, 48, 6, (2020)